The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Homocysteine and other sulfhydryl compounds enhance the binding of lipoprotein(a) to fibrin: a potential biochemical link between thrombosis, atherogenesis, and sulfhydryl compound metabolism.
Open accessAbstract
We have previously shown that lipoprotein(a) [Lp(a)], an atherogenic lipoprotein that contains apolipoprotein(a), which shares partial structural homology to plasminogen, binds to a plasmin-modified fibrin surface, and we have postulated that this interaction may be atherogenic. Moderate elevations in blood homocysteine, a relatively common condition, predispose to premature atherosclerosis. The reasons for this are not established. We now report that homocysteine, at concentrations as low as 8 microM, significantly increases the affinity of Lp(a) for fibrin. Homocysteine induces a 20-fold increase in the affinity between Lp(a) and plasmin-treated fibrin and a 4-fold increase with unmodified fibrin. Lp(a) binding is inhibited by epsilon-aminocaproic acid, indicating lysine binding site specificity. Homocysteine does not enhance the binding of Lp(a) to other surface-bound proteins. Cysteine, glutathione, and N-acetylcysteine also increase the affinity between Lp(a) and fibrin. Homocysteine does not affect the binding of low density lipoprotein or plasminogen to fibrin, nor does it alter the gel-filtration elution pattern of Lp(a). Immunoblot analysis documents the fact that homocysteine partially reduces Lp(a). These results suggest that homocysteine alters the intact Lp(a) particle so as to increase the reactivity of the plasminogen-like apolipoprotein(a) portion of the molecule. The observation that sulfhydryl amino acids increase Lp(a) binding to fibrin suggests a biochemical relationship between sulfhydryl compound metabolism, thrombosis, and atherogenesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
Clarke, R., Daly, L., Robinson, K., Naughten, E., Cahalane, S., Fowler, B., & Graham, I. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241701 · Cited by 2,161
Glutathione metabolism and its selective modification.
Meister, A. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77815-6 · Cited by 2,011
cDNA sequence of human apolipoprotein(a) is homologous to plasminogen
McLean, J. W., Tomlinson, J. E., Kuang, W.-J., Eaton, D. L., Chen, E. Y., Fless, G. M., Scanu, A. M., & Lawn, R. M. (1987) · Nature · doi:10.1038/330132a0 · Cited by 1,886
A NEW SERUM TYPE SYSTEM IN MAN—THE Lp SYSTEM
Berg, K. (1963) · Acta Pathologica Microbiologica Scandinavica · doi:10.1111/j.1699-0463.1963.tb01808.x · Cited by 1,372
Harker, L. A., Ross, R., Slichter, S. J., & Scott, C. R. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108520 · Cited by 933
Endothelial cell injury due to copper-catalyzed hydrogen peroxide generation from homocysteine.
Starkebaum, G., & Harlan, J. M. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112442 · Cited by 822
Lp(a) Lipoprotein as a Risk Factor for Myocardial Infarction
Rhoads, G. G. (1986) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1986.03380180102027 · Cited by 783
Heterozygosity for Homocystinuria in Premature Peripheral and Cerebral Occlusive Arterial Disease
Boers, G. H. J., Smals, A. G. H., Trijbels, F. J. M., Fowler, B., Bakkeren, J. A. J. M., Schoonderwaldt, H. C., Kleijer, W. J., & Kloppenborg, P. W. C. (1985) · New England Journal of Medicine · doi:10.1056/nejm198509193131201 · Cited by 732
Hajjar, K. A., Gavishi, D., Breslow, J. L., & Nachman, R. L. (1989) · Nature · doi:10.1038/339303a0 · Cited by 702
Ueland, P. M., & Refsum, H. (1989) · PubMed · Cited by 688
Seed, M., Hoppichler, F., Reaveley, D., McCarthy, S., Thompson, G. R., Boerwinkle, E., & Utermann, G. (1990) · New England Journal of Medicine · doi:10.1056/nejm199005243222104 · Cited by 585
A potential basis for the thrombotic risks associated with lipoprotein(a)
Miles, L. A., Fless, G. M., Levin, E. G., Scanu, A. M., & Plow, E. F. (1989) · Nature · doi:10.1038/339301a0 · Cited by 583
Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease.
Malinow, M. R., Kang, S. S., Taylor, L. M., Wong, P. W., Coull, B., Inahara, T., Mukerjee, D., Sexton, G., & Upson, B. (1989) · Circulation · doi:10.1161/01.cir.79.6.1180 · Cited by 501
Homocysteine-induced endothelial cell injury in vitro: A model for the study of vascular injury
Wall, R. T., Harlan, J. M., Harker, L. A., & Striker, G. E. (1980) · Thrombosis Research · doi:10.1016/0049-3848(80)90175-9 · Cited by 483
Lipoprotein(a), fibrin binding, and plasminogen activation.
Loscalzo, J., Weinfeld, M., Fless, G. M., & Scanu, A. M. (1990) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.10.2.240 · Cited by 461
Heinecke, J. W., Rosen, H., Suzuki, L. A., & Chait, A. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61082-8 · Cited by 460
Detection and quantification of lipoprotein(a) in the arterial wall of 107 coronary bypass patients.
Rath, M., Niendorf, A., Reblin, T., Dietel, M., Krebber, H. J., & Beisiegel, U. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.579 · Cited by 446
Partial amino acid sequence of apolipoprotein(a) shows that it is homologous to plasminogen.
Eaton, D. L., Fless, G. M., Kohr, W. J., McLean, J. W., Xu, Q. T., Miller, C. G., Lawn, R. M., & Scanu, A. M. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.10.3224 · Cited by 416
Rodgers, G., & Conn, M. (1990) · Blood · doi:10.1182/blood.v75.4.895.895 · Cited by 398
Activation of endogenous factor V by a homocysteine-induced vascular endothelial cell activator.
Rodgers, G. M., & Kane, W. H. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112519 · Cited by 384
Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction
MURAI, A., MIYAHARA, T., FUJIMOTO, N., MATSUDA, M., & KAMEYAMA, M. (1986) · Atherosclerosis · doi:10.1016/0021-9150(86)90048-1 · Cited by 383
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
Zenker, G., Költringer, P., Boné, G., Niederkorn, K., Pfeiffer, K., & Jürgens, G. (1986) · Stroke · doi:10.1161/01.str.17.5.942 · Cited by 329
Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
Coull, B. M., Malinow, M. R., Beamer, N., Sexton, G., Nordt, F., & de Garmo, P. (1990) · Stroke · doi:10.1161/01.str.21.4.572 · Cited by 308
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin.
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.10.3847 · Cited by 285
Self-citationCushing, G. L., Gaubatz, J. W., Nava, M. L., Burdick, B. J., Bocan, T. M., Guyton, J. R., Weilbaecher, D., DeBakey, M. E., Lawrie, G. M., & Morrisett, J. D. (1989) · Arteriosclerosis: An Official Journal of the American Heart Association, Inc. · doi:10.1161/01.atv.9.5.593 · Cited by 252
Hoff, H. F., Beck, G. J., Skibinski, C. I., Jürgens, G., O'Neil, J., Kramer, J., & Lytle, B. (1988) · Circulation · doi:10.1161/01.cir.77.6.1238 · Cited by 249
Effect of sulfinpyrazone on homocysteine-induced endothelial injury and arteriosclerosis in baboons.
Harker, L. A., Harlan, J. M., & Ross, R. (1983) · Circulation Research · doi:10.1161/01.res.53.6.731 · Cited by 243
Teaching old dogmas new tricks
Brown, M. S., & Goldstein, J. L. (1987) · Nature · doi:10.1038/330113a0 · Cited by 238
Parthasarathy, S. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90139-1 · Cited by 233
Armstrong, V. W., Walli, A. K., & Seidel, D. (1985) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)34257-7 · Cited by 224
Gonzalez-Gronow, M., Edelberg, J. M., & Pizzo, S. V. (1989) · Biochemistry · doi:10.1021/bi00432a005 · Cited by 218
Lipoprotein(a) as a strong indicator for cerebrovascular disease.
GZenker, PKöltringer, GBoné, et al. (1986) · Stroke · Cited by 197
Harpel, P. C. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110253 · Cited by 173
Self-citationA New Serum Type System in Man — The Ld System
Berg, K. (1965) · Vox Sanguinis · doi:10.1111/j.1423-0410.1965.tb01404.x · Cited by 155
Apolipoprotein(a) size heterogeneity is related to variable number of repeat sequences in its mRNA
Koschinsky, M. L., Beisiegel†, U., Henne‐Bruns, D., Eaton, D., & Lawn, R. M. (1990) · Biochemistry · doi:10.1021/bi00455a007 · Cited by 149
Rouy, D., Grailhe, P., Nigon, F., Chapman, J., & Anglés‐Cano, E. (1991) · Arteriosclerosis and Thrombosis A Journal of Vascular Biology · doi:10.1161/01.atv.11.3.629 · Cited by 148
Quantification of apo[a] and apoB in human atherosclerotic lesions.
Pepin, J. M., O'Neil, J., & Hf, H. (1991) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)42092-9 · Cited by 143
Endothelial cell dysfunction in homocystinuria
de Groot, P. G., Willems, C. E. D., Boers, G. H. J., et al. (1983) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1983.tb00121.x · Cited by 138
Harpel, P. C., Chang, T. S., & Verderber, E. L. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)89283-3 · Cited by 137
Self-citationSmith, E. B., Keen, G. A., & GRANT, A. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90087-y · Cited by 115
Effect of Homocysteine and Homocystine on Platelet and Vascular Arachidonic Acid Metabolism
Graeber, J. E., Slott, J. H., Ulane, R. E., Schulman, J. D., & Stuart, M. J. (1982) · Pediatric Research · doi:10.1203/00006450-198206000-00018 · Cited by 112
Smith, E. B., & Cochran, S. (1990) · Atherosclerosis · doi:10.1016/0021-9150(90)90088-z · Cited by 111
Niendorf, A., Rath, M., Wolf, K., et al. (1990) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf02190527 · Cited by 93
Plasmin catalyzes binding of lipoprotein (a) to immobilized fibrinogen and fibrin
Harpel, P. C., Gordon, B. R., & Parker, T. S. (1989) · Fibrinolysis and Proteolysis · doi:10.1016/0268-9499(89)90176-8 · Cited by 56
Self-citationLipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase.
Borth, W., Chang, V. T.-S., Bishop, P. D., et al. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55248-0 · Cited by 47
Self-citation
Cited by
Homocysteine and Cardiovascular Disease
Refsum, H., Ueland, P. M., Nygård, O., & Vollset, S. E. (1998) · Annual Review of Medicine · doi:10.1146/annurev.med.49.1.31 · Cited by 2,180
Mice deficient in cystathionine beta-synthase: animal models for mild and severe homocyst(e)inemia.
Watanabe, M., Osada, J., Aratani, Y., Kluckman, K., Reddick, R., Malinow, M. R., & Maeda, N. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1585 · Cited by 569
Bostom, A. G., & Lathrop, L. (1997) · Kidney International · doi:10.1038/ki.1997.298 · Cited by 456
Homocysteine and Thrombotic Disease
D'Angelo, A., & Selhub, J. (1997) · Blood · doi:10.1182/blood.v90.1.1 · Cited by 439
Kokame, K., Kato, H., & Miyata, T. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.47.29659 · Cited by 360
Metadata
- Authors
- Harpel, P. C., Chang, V. T., & Borth, W.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1992-11
- Volume
- 89
- Issue
- 21
- Pages
- 10193-10197
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2092004637
- Cited by
- 259
- References
- 45
- FWCI
- 9.23
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.